Background: Patients who travel more than 60 min to undergo hemodialysis may experience higher mortality and lower quality of life. The primary aim of this study was to calculate the travel distance between patient city areas and dialysis facility care locations in Brazil, to highlight barriers and need to optimize access to chronic dialysis. Methods: We conducted a retrospective cohort study using claims data from the Brazilian Public Health System's database, focusing on kidney replacement therapy (KRT) by hemodialysis. Our study population comprised all patients undergoing hemodialysis in Brazil between January 2023 and December 2023. For patients from different city areas, we calculated the Haversine distance between the patient city area and the dialysis facility. Results: We evaluated 154,788 patients who received hemodialysis funded by the Brazilian Public Health System. Fifty-nine percent of the patients underwent dialysis in the same city area. Overall, patients traveled a median (IQR) distance of 35.9 [19.5 – 64.2] kilometers to the facilities, 48% traveled more than 40 km, with a maximum traveling distance of 353 km. Notably, the median distance traveled was shortest in the Southeast (27.6 km) and longest in the North (84.3 km). The number of patients that traveled more than 40 km was lower in the Southeast (32%) and higher in the North region (77%). Conclusion: The travel distance to the dialysis facility is an important inequity to KRT access in Brazil. In the South and Southeast, where there is a higher dialysis unit density, patients have greater regional availability of dialysis centers, and shorter traveling distances than in the North, Midwest, and Northeast regions. Graphical
Studies that use medical records are often impeded due to the information presented in narrative fields. However, recent studies have used artificial intelligence to extract and process secondary health data from electronic medical records. The aim of this study was to develop a neural network that uses data from unstructured medical records to capture information regarding symptoms, diagnoses, medications, conditions, exams, and treatment. Data from 30,000 medical records of patients hospitalized in the Clinical Hospital of the Botucatu Medical School (HCFMB), São Paulo, Brazil, were obtained, creating a corpus with 1200 clinical texts. A natural language algorithm for text extraction and convolutional neural networks for pattern recognition were used to evaluate the model with goodness-of-fit indices. The results showed good accuracy, considering the complexity of the model, with an F-score of 63.9% and a precision of 72.7%. The patient condition class reached a precision of 90.3% and the medication class reached 87.5%. The proposed neural network will facilitate the detection of relationships between diseases and symptoms and prevalence and incidence, in addition to detecting the identification of clinical conditions, disease evolution, and the effects of prescribed medications.
Background: Brazil has the world’s largest public organ transplant program, which was severely affected by the COVID-19 pandemic. The primary aim of the study was to evaluate differences in solid organ transplants and rejection episodes during the COVID-19 pandemic compared to the five years before the pandemic in the country. Methods: A seven-year database was built by downloading data from the DATASUS server. The pandemic period was defined as March 2020 to December 2021. The pre-pandemic period was from January 2015 to March 2020. Results: During the pandemic, the number of solid organ transplants decreased by 19.3% in 2020 and 22.6% in 2021 compared to 2019. We found a decrease for each evaluated organ, which was more pronounced for lung, pancreas, and kidney transplants. The seasonal plot of rejection data indicated a high rejection rate between 2018 and 2021. There was also an 18% (IRR 1.18 (95% CI 1.01 to 1.37), p = 0.04) increase in the rejection rate during the COVID-19 pandemic. Conclusions: The total number of organ transplants performed in 2021 represents a setback of six years. Transplant procedures were concentrated in the Southeast region of the country, and a higher proportion of rejections occurred during the pandemic. Together, these findings could have an impact on transplant procedures and outcomes in Brazil.
Background: Thrombotic Microangiopathy (TMA) is a syndrome characterized by the presence of anemia, thrombocytopenia and organ damage and has multiple etiologies. The primary aim is to develop an algorithm to classify TMA (TMA-INSIGHT score). Methods: This was a single-center retrospective cohort study including hospitalized patients with TMA at a single center. We included all consecutive patients diagnosed with TMA between 2012 and 2021. TMA was defined based on the presence of anemia (hemoglobin level < 10 g/dL) and thrombocytopenia (platelet count < 150,000/µL), signs of hemolysis, and organ damage. We classified patients in eight categories: infections; Malignant Hypertension; Transplant; Malignancy; Pregnancy; Thrombotic Thrombocytopenic Purpura (TTP); Shiga toxin-mediated hemolytic uremic syndrome (STEC-SHU) and Complement Mediated TMA (aHUS). We fitted a model to classify patients using clinical characteristics, biochemical exams, and mean arterial pressure at presentation. Results: We retrospectively retrieved TMA phenotypes using automatic strategies in electronic health records in almost 10 years (n = 2407). Secondary TMA was found in 97.5% of the patients. Primary TMA was found in 2.47% of the patients (TTP and aHUS). The best model was LightGBM with accuracy of 0.979, and multiclass ROC-AUC of 0.966. The predictions had higher accuracy in most TMA classes, although the confidence was lower in aHUS and STEC-HUS cases. Conclusion: Secondary conditions were the most common etiologies of TMA. We retrieved comorbidities, associated conditions, and mean arterial pressure to fit a model to predict TMA and define TMA phenotypic characteristics. This is the first multiclass model to predict TMA including primary and secondary conditions.
5 September 2025 in Journal of Imaging Informatics in Medicine
Breast cancer is the leading cause of cancer-related deaths among women worldwide. Early detection through mammography significantly improves outcomes, with breast density acting as both a risk factor and a key interpretive feature. Although the Breast Imaging Reporting and Data System (BI-RADS) provides standardized density categories, assessments are often subjective and variable. While automated tools exist, most are proprietary and resource-intensive, limiting their use in underserved settings. There is a critical need for accessible, low-cost AI solutions that provide consistent breast density classification. This study aims to develop and evaluate an open-source, computer vision-based approach using deep learning techniques for objective breast density assessment in mammography images, with a focus on accessibility, consistency, and applicability in resource-limited healthcare environments. Our approach integrates a custom-designed convolutional neural network (CD-CNN) with an extreme learning machine (ELM) layer for image-based breast density classification. The retrospective dataset includes 10,371 full-field digital mammography images, previously categorized by radiologists into one of four BI-RADS breast density categories (A–D). The proposed model achieved a testing accuracy of 95.4%, with a specificity of 98.0% and a sensitivity of 92.5%. Agreement between the automated breast density classification and the specialists’ consensus was strong, with a weighted kappa of 0.90 (95% CI: 0.82–0.98). On the external and independent mini-MIAS dataset, the model achieved an accuracy of 73.9%, a precision of 81.1%, a specificity of 87.3%, and a sensitivity of 75.1%, which is comparable to the performance reported in previous studies using this dataset. The proposed approach advances breast density assessment in mammograms, enhancing accuracy and consistency to support early breast cancer detection.